Ilaria Cutini - Concepedia

Author

Ilaria Cutini

Azienda Ospedaliero-Universitaria Careggi ORCID

Also Known As

Cutini I, I. Cutini, Ilaria Cutini, Tsila Rosenvald-Zuckerman

Publications

316

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliero-Universitaria Careggi Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Università degli Studi del Piemonte Orientale “Amedeo Avogadro”Ospedale Papa Giovanni XXIII University of Florence

About

Ilaria Cutini is an author at Azienda Ospedaliero-Universitaria Careggi specializing in medicine, tumor biology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	65
2	Cell Biology	2	2	36
3	Immunology	2	2	36
4	Pathology	2	2	36
5	Pharmacology	1	1	29

Ilaria Cutini

Publications

205

Citations

H-Index

Page 1

	Year	Citations
<i>CEBPA</i> –double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features Francesco Mannelli, Vanessa Ponziani, Sara Bencini, Haematologica	2016	70
Cytarabine and clofarabine after high‐dose cytarabine in relapsed or refractory AML patients Barbara Scappini, Giacomo Gianfaldoni, F Caracciolo, American Journal of Hematology Intermediate Dose CytarabineTranslational MedicineHigh‐dose CytarabineOncologyClinical Therapeutic	2012	29
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study Annalisa Chiappella, Beatrice Casadei, Patrizia Chiusolo, Leukemia	2024	27
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Cytometry Part B Clinical Cytometry High Cxcr4 ExpressionTumor BiologyHematological MalignancyMixed-phenotype Acute LeukemiaAcute Myeloid Leukemia	2014	23
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial Giacomo Gianfaldoni, Francesco Mannelli, Tamara Intermesoli, Blood Advances	2020	15
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas Federico Stella, Annalisa Chiappella, Beatrice Casadei, Blood Cancer Discovery	2024	15
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Cytometry Part B Clinical Cytometry High Cxcr4 ExpressionTumor BiologyHematological MalignancyCxcr4 ExpressionAcute Myeloid Leukemia	2014	13
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study Maria Caterina Cavallo, Marianna Cavazza, Francesca Bonifazi, BMC Health Services Research	2024	13

Page 1